SHARE
Radiopharmaceutical Market

Radiopharmaceutical - Global Market Outlook (2019-2027)

4.3 (78 reviews)
Published: June 2020 ID: SMRC19374
4.3 (78 reviews)
Published: June 2020 ID: SMRC19374

This report covers the impact of COVID-19 on this global market

According to Stratistics MRC, the Global Radiopharmaceutical Market is accounted for $3.76 billion in 2019 and is expected to reach $5.99 billion by 2027 growing at a CAGR of 6.0% during the forecast period. Some of the key factors propelling the market growth are technological advancements in the diagnostics sector, increasing prevalence of cancer, and increasing applications of molecular imaging. However, the short half-life of radioisotopes is the restraining factor for the growth of the market.

Pharmaceutical formulations that contain radioisotopes are known as radiopharmaceuticals. These are bound with the biological molecules and are targeted for the specific organs. The molecules resulting from these formulations find a wide range of applications in the therapeutic and diagnostic sectors.

By radioisotope, the Technetium-99 segment is expected to grow at a significant market share during the forecast period owing to its easy availability and extensive diagnostic applications. Based on geography, North America is anticipated to hold considerable market share during the forecast period owing to the presence of radioisotope sources in the region.

Some of the key players in Radiopharmaceutical Market include Lantheus Medical Imaging, Inc, GE Healthcare, Advanced Accelerator Applications, Mallinckrodt, Bayer AG, Siemens Healthineers, IBA Radiopharma Solutions, Eckert & Ziegler, Philips, Jubilant Life Sciences Limited, Novartis AG, BWX Technologies, Inc., POLATOM, JSC Isotope, NTP Radioisotopes SOC Ltd, Curium, Australian Nuclear Science and Technology Organization (ANSTO), Cardinal Health Inc., Covidien Plc, Positron Corporation, Monrol Nuclear Products,Inc, and Nordion, Inc.

Sources Covered:
• Nuclear Reactors
• Cyclotrons

Types Covered:
• Therapeutic
• Diagnostic

Radioisotopes Covered:
• Yttrium-90
• Thallium-201
• Technetium-99
• Strontium -89
• Samarium-153
• Rubidium-82
• Rhenium-186
• Radium-223
• Palladium - 103
• Leutetium-177
• Iridium - 192
• Iodine-131
• Iodine-125
• Iodine-123
• Indium-111
• Holmium-166
• Gallium-68
• Gallium-67
• Fluorine-18
• Fludeoxyglucose - (18F-FDG)
• Erbium-169
• Cesium-131
• Actinium-225

Applications Covered:
• Thyroid
• Theranostics
• Oncology
• Neurology
• Neuroendocrinology
• Nephrology
• Lymphoma
• Inflammation
• Gastroenterology
• Cardiology

End Users Covered:
• Ambulatory Surgical Centers
• Cancer Research Institute
• Diagnostic Imaging Centers
• Hospitals

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK 
o Spain
o Rest of Europe      
• Asia Pacific
o Japan       
o China       
o India       
o Australia       
o New Zealand      
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2018, 2019, 2020, 2024 and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis, etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary    
      
2 Preface     

 2.1 Abstract    
 2.2 Stake Holders   
 2.3 Research Scope   
 2.4 Research Methodology  
  2.4.1 Data Mining  
  2.4.2 Data Analysis  
  2.4.3 Data Validation  
  2.4.4 Research Approach  
 2.5 Research Sources   
  2.5.1 Primary Research Sources 
  2.5.2 Secondary Research Sources 
  2.5.3 Assumptions  
      
3 Market Trend Analysis   
 3.1 Introduction   
 3.2 Drivers    
 3.3 Restraints    
 3.4 Opportunities   
 3.5 Threats    
 3.6 Application Analysis   
 3.7 End User Analysis   
 3.8 Emerging Markets   
 3.9 Impact of Covid-19   
      
4 Porters Five Force Analysis   
 4.1 Bargaining power of suppliers  
 4.2 Bargaining power of buyers  
 4.3 Threat of substitutes   
 4.4 Threat of new entrants  
 4.5 Competitive rivalry   
      
5 Global Radiopharmaceutical Market, By Source 
 5.1 Introduction   
 5.2 Nuclear Reactors   
 5.3 Cyclotrons   
      
6 Global Radiopharmaceutical Market, By Type 
 6.1 Introduction   
 6.2 Therapeutic   
  6.2.1 Alpha Emitters  
  6.2.2 Beta Emitters  
  6.2.3 Brachytherapy Isotopes 
 6.3 Diagnostic   
  6.3.1 Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals
  6.3.2 Positron Emission Tomography (PET) Radiopharmaceuticals
      
7 Global Radiopharmaceutical Market, By Radioisotope
 7.1 Introduction   
 7.2 Yttrium-90   
 7.3 Thallium-201   
 7.4 Technetium-99   
 7.5 Strontium -89   
 7.6 Samarium-153   
 7.7 Rubidium-82   
 7.8 Rhenium-186   
 7.9 Radium-223   
 7.10 Palladium - 103   
 7.11 Leutetium-177   
 7.12 Iridium - 192   
 7.13 Iodine-131   
 7.14 Iodine-125   
 7.15 Iodine-123   
 7.16 Indium-111   
 7.17 Holmium-166   
 7.18 Gallium-68   
 7.19 Gallium-67   
 7.20 Fluorine-18   
 7.21 Fludeoxyglucose - (18F-FDG)  
 7.22 Erbium-169   
 7.23 Cesium-131
  
 7.24 Actinium-225   
      
8 Global Radiopharmaceutical Market, By Application 
 8.1 Introduction   
 8.2 Thyroid    
 8.3 Theranostics   
 8.4 Oncology    
 8.5 Neurology   
 8.6 Neuroendocrinology   
 8.7 Nephrology   
 8.8 Lymphoma   
 8.9 Inflammation   
 8.10 Gastroenterology   
 8.11 Cardiology   
      
9 Global Radiopharmaceutical Market, By End User 
 9.1 Introduction   
 9.2 Ambulatory Surgical Centers  
 9.3 Cancer Research Institute  
 9.4 Diagnostic Imaging Centers  
 9.5 Hospitals    
      
10 Global Radiopharmaceutical Market, By Geography 
 10.1 Introduction   
 10.2 North America   
  10.2.1 US   
  10.2.2 Canada   
  10.2.3 Mexico   
 10.3 Europe    
  10.3.1 Germany   
  10.3.2 UK   
  10.3.3 Italy   
  10.3.4 France   
  10.3.5 Spain   
  10.3.6 Rest of Europe  
 10.4 Asia Pacific   
  10.4.1 Japan   
  10.4.2 China   
  10.4.3 India   
  10.4.4 Australia   
  10.4.5 New Zealand  
  10.4.6 South Korea  
  10.4.7 Rest of Asia Pacific  
 10.5 South America   
  10.5.1 Argentina   
  10.5.2 Brazil   
  10.5.3 Chile   
  10.5.4 Rest of South America 
 10.6 Middle East & Africa   
  10.6.1 Saudi Arabia  
  10.6.2 UAE   
  10.6.3 Qatar   
  10.6.4 South Africa  
  10.6.5 Rest of Middle East & Africa 
      
11 Key Developments    
 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
 11.2 Acquisitions & Mergers  
 11.3 New Product Launch   
 11.4 Expansions   
 11.5 Other Key Strategies   
      
12 Company Profiling    
 12.1 Lantheus Medical Imaging, Inc  
 12.2 GE Healthcare   
 12.3 Advanced Accelerator Applications 
 12.4 Mallinckrodt   
 12.5 Bayer AG    
 12.6 Siemens Healthineers  
 12.7 IBA Radiopharma Solutions  
 12.8 Eckert & Ziegler   
 12.9 Philips    
 12.10 Jubilant Life Sciences Limited  
 12.11 Novartis AG   
 12.12 BWX Technologies, Inc.  
 12.13 POLATOM   
 12.14 JSC Isotope   
 12.15 NTP Radioisotopes SOC Ltd  
 12.16 Curium    
 12.17 Australian Nuclear Science and Technology Organization (ANSTO)
 12.18 Cardinal Health Inc.   
 12.19 Covidien Plc   
 12.20 Positron Corporation  
 12.21 Monrol Nuclear Products,Inc  
 12.22 Nordion,Inc.  


List of Tables     
1 Global Radiopharmaceutical Market Outlook, By Region (2018-2027) ($MN)
2 Global Radiopharmaceutical Market Outlook, By Source (2018-2027) ($MN)
3 Global Radiopharmaceutical Market Outlook, By Nuclear Reactors (2018-2027) ($MN)
4 Global Radiopharmaceutical Market Outlook, By Cyclotrons (2018-2027) ($MN)
5 Global Radiopharmaceutical Market Outlook, By Type (2018-2027) ($MN)
6 Global Radiopharmaceutical Market Outlook, By Therapeutic (2018-2027) ($MN)
7 Global Radiopharmaceutical Market Outlook, By Alpha Emitters (2018-2027) ($MN)
8 Global Radiopharmaceutical Market Outlook, By Beta Emitters (2018-2027) ($MN)
9 Global Radiopharmaceutical Market Outlook, By Brachytherapy Isotopes (2018-2027) ($MN)
10 Global Radiopharmaceutical Market Outlook, By Diagnostic (2018-2027) ($MN)
11 Global Radiopharmaceutical Market Outlook, By Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals (2018-2027) ($MN)
12 Global Radiopharmaceutical Market Outlook, By Positron Emission Tomography (PET) Radiopharmaceuticals (2018-2027) ($MN)
13 Global Radiopharmaceutical Market Outlook, By Radioisotope (2018-2027) ($MN)
14 Global Radiopharmaceutical Market Outlook, By Yttrium-90 (2018-2027) ($MN)
15 Global Radiopharmaceutical Market Outlook, By Thallium-201 (2018-2027) ($MN)
16 Global Radiopharmaceutical Market Outlook, By Technetium-99 (2018-2027) ($MN)
17 Global Radiopharmaceutical Market Outlook, By Strontium -89 (2018-2027) ($MN)
18 Global Radiopharmaceutical Market Outlook, By Samarium-153 (2018-2027) ($MN)
19 Global Radiopharmaceutical Market Outlook, By Rubidium-82 (2018-2027) ($MN)
20 Global Radiopharmaceutical Market Outlook, By Rhenium-186 (2018-2027) ($MN)
21 Global Radiopharmaceutical Market Outlook, By Radium-223 (2018-2027) ($MN)
22 Global Radiopharmaceutical Market Outlook, By Palladium - 103 (2018-2027) ($MN)
23 Global Radiopharmaceutical Market Outlook, By Leutetium-177 (2018-2027) ($MN)
24 Global Radiopharmaceutical Market Outlook, By Iridium - 192 (2018-2027) ($MN)
25 Global Radiopharmaceutical Market Outlook, By Iodine-131 (2018-2027) ($MN)
26 Global Radiopharmaceutical Market Outlook, By Iodine-125 (2018-2027) ($MN)
27 Global Radiopharmaceutical Market Outlook, By Iodine-123 (2018-2027) ($MN)
28 Global Radiopharmaceutical Market Outlook, By Indium-111 (2018-2027) ($MN)
29 Global Radiopharmaceutical Market Outlook, By Holmium-166 (2018-2027) ($MN)
30 Global Radiopharmaceutical Market Outlook, By Gallium-68 (2018-2027) ($MN)
31 Global Radiopharmaceutical Market Outlook, By Gallium-67 (2018-2027) ($MN)
32 Global Radiopharmaceutical Market Outlook, By Fluorine-18 (2018-2027) ($MN)
33 Global Radiopharmaceutical Market Outlook, By Fludeoxyglucose - (18F-FDG) (2018-2027) ($MN)
34 Global Radiopharmaceutical Market Outlook, By Erbium-169 (2018-2027) ($MN)
35 Global Radiopharmaceutical Market Outlook, By Cesium-131 (2018-2027) ($MN)
36 Global Radiopharmaceutical Market Outlook, By Actinium-225 (2018-2027) ($MN)
37 Global Radiopharmaceutical Market Outlook, By Application (2018-2027) ($MN)
38 Global Radiopharmaceutical Market Outlook, By Thyroid (2018-2027) ($MN)
39 Global Radiopharmaceutical Market Outlook, By Theranostics (2018-2027) ($MN)
40 Global Radiopharmaceutical Market Outlook, By Oncology (2018-2027) ($MN)
41 Global Radiopharmaceutical Market Outlook, By Neurology (2018-2027) ($MN)
42 Global Radiopharmaceutical Market Outlook, By Neuroendocrinology (2018-2027) ($MN)
43 Global Radiopharmaceutical Market Outlook, By Nephrology (2018-2027) ($MN)
44 Global Radiopharmaceutical Market Outlook, By Lymphoma (2018-2027) ($MN)
45 Global Radiopharmaceutical Market Outlook, By Inflammation (2018-2027) ($MN)
46 Global Radiopharmaceutical Market Outlook, By Gastroenterology (2018-2027) ($MN)
47 Global Radiopharmaceutical Market Outlook, By Cardiology (2018-2027) ($MN)
48 Global Radiopharmaceutical Market Outlook, By End User (2018-2027) ($MN)
49 Global Radiopharmaceutical Market Outlook, By Ambulatory Surgical Centers (2018-2027) ($MN)
50 Global Radiopharmaceutical Market Outlook, By Cancer Research Institute (2018-2027) ($MN)
51 Global Radiopharmaceutical Market Outlook, By Diagnostic Imaging Centers (2018-2027) ($MN)
52 Global Radiopharmaceutical Market Outlook, By Hospitals (2018-2027) ($MN)
      
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Allows one person to have access to the ordered product.The ordered product cannot be distributed to anyone else.
Allows the ordered product to be shared among a maximum of 5 people within your organisation.
Allows the product to be shared among all employees of your organisation at one particular location.
Allows the product to be shared among all employees of your organisation regardless of their geographical location.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials